Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
ContributorsBlack, Steven; Eskola, Juhani; Siegrist, Claire-Anne; Halsey, Neal; Macdonald, Noni; Law, Barbara; Miller, Elizabeth; Andrews, Nick; Stowe, Julia; Salmon, Daniel; Vannice, Kirsten; Izurieta, Hector S.; Akhtar, Aysha; Gold, Mike; Oselka, Gabriel; Zuber, Patrick; Pfeifer, Dina; Vellozzi, Claudia
Published inLancet, vol. 374, no. 9707, p. 2115-2122
Publication date2009
Abstract
Keywords
- Adolescent
- Adult
- Child, Preschool
- Female
- Guillain-Barre Syndrome
- Humans
- Influenza A Virus, H1N1 Subtype/*immunology
- Influenza Vaccines/adverse effects/*standards
- Male
- *Mass Vaccination/adverse effects
- Multiple Sclerosis/etiology
- Myelitis, Transverse/etiology
- Neuritis/etiology
- Obstetric Labor, Premature/etiology
- Optic Neuritis/etiology
- Pregnancy
Affiliation entities
Research groups
Citation (ISO format)
BLACK, Steven et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. In: Lancet, 2009, vol. 374, n° 9707, p. 2115–2122. doi: 10.1016/S0140-6736(09)61877-8
Main files (1)
Article
Identifiers
- PID : unige:19683
- DOI : 10.1016/S0140-6736(09)61877-8
- PMID : 19880172
Additional URL for this publicationhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861912/pdf/nihms183100.pdf
Journal ISSN0140-6736